Yes, you can file a class action lawsuit against a health insurance company for denial of coverage, and policyholders are doing exactly that right now with increasing success. Several major lawsuits filed against UnitedHealth Group, Cigna, and Humana have advanced through the courts in 2024 and 2025, with federal judges allowing claims for breach of contract and bad faith to proceed. The key legal question is whether your insurer systematically denied claims using flawed processes, automated algorithms, or AI tools rather than the individualized clinical review your policy promised. The scale of the problem is staggering.
In 2024, approximately 8.8 million out of 46 million in-network claims were denied across HealthCare.gov states. While the overall denial rate dropped to 19.1% from 22.5% in 2023, that still represents nearly one in five claims getting rejected. What makes class actions viable is a pattern that keeps emerging in litigation: 77% of those denials stem from paperwork or plan design issues, not actual medical judgment. When an insurer uses the same flawed system to deny thousands of claims, that is precisely the kind of common injury that class action law was designed to address.
Table of Contents
- When Can You Sue a Health Insurer in a Class Action for Denying Coverage?
- Landmark Class Action Lawsuits Against Insurers Using AI to Deny Claims
- Federal Laws That Govern Health Insurance Denials and Your Right to Appeal
- How State Laws Are Strengthening Your Right to Challenge Denials
- The Denial Rate Crisis and Why 77% of Denials Are Not About Medicine
- How ERISA Fiduciary Claims Are Opening a New Front Against Insurers
- What Comes Next for Health Insurance Denial Class Actions
- Frequently Asked Questions
When Can You Sue a Health Insurer in a Class Action for Denying Coverage?
A class action against a health insurer requires what any class action requires: a group of people who suffered the same type of harm from the same conduct. In the health insurance context, that means showing your insurer used a systematic practice — not just a one-off mistake — to deny claims improperly. The most successful recent cases involve insurers deploying algorithms or AI tools to process denials in bulk, bypassing the clinical review that policy language and federal law require. For example, in the Cigna PXDX algorithm lawsuit filed in the U.S. District Court for the Eastern District of California on July 24, 2024, patients alleged that Cigna used its PXDX algorithm to automatically deny claims in batches of hundreds or thousands without individualized review. However, not every denial qualifies for class treatment.
If your claim was denied based on a genuinely individualized medical review and you simply disagree with the outcome, that is typically an individual dispute better handled through the appeals process. Class actions gain traction when discovery reveals that the insurer applied a blanket rule, defective algorithm, or cost-cutting protocol across a broad population of policyholders. The distinction matters because courts will examine whether common questions of law and fact predominate over individual issues before certifying a class. One important limitation: if your health plan is employer-sponsored and governed by ERISA (the Employee Retirement Income Security Act), your remedies may be more constrained than if you hold an individual or state-regulated plan. ERISA preempts many state-law claims, which historically limited what plaintiffs could recover. That said, the recent wave of AI denial lawsuits is testing those boundaries, and courts have been willing to let breach of contract and bad faith claims proceed even in the ERISA context.
Landmark Class Action Lawsuits Against Insurers Using AI to Deny Claims
The most significant class action in this space right now is Lokken v. UnitedHealth Group. On February 13, 2025, a federal court allowed breach of contract and bad faith claims to proceed after finding that UnitedHealth’s use of an AI tool called nH Predict may have violated policy language requiring coverage decisions to be made by clinical staff. The tool reportedly had a 90% error rate when denials were appealed — meaning that nine out of ten times a patient challenged an AI-generated denial, the denial was overturned. That statistic alone tells you the system was not functioning as a legitimate clinical review tool. It was functioning as a cost-reduction mechanism dressed up as medical judgment. Cigna and Humana face similar allegations.
The Cigna PXDX lawsuit targets the company’s practice of using an algorithm to batch-deny claims without human review. Humana was sued for using AI to deny Medicare Advantage claims, a particularly concerning practice given that Medicare Advantage enrollees are often elderly and less equipped to navigate complex appeals processes. These cases share a common thread: the insurer’s own policy language and federal regulations require that trained clinical professionals make coverage determinations, and plaintiffs allege that delegating those decisions to an algorithm violates that requirement. Beyond AI-specific cases, traditional denial practice lawsuits continue to move forward. In June 2025, a federal judge approved class-action status in a case against Montana Blue Cross Blue Shield after finding evidence that BCBS routinely denied claims without the investigation and documentation required by state law. This case is notable because it did not involve AI at all — just old-fashioned corner-cutting on the claims review process. It demonstrates that class actions remain viable even when the insurer’s misconduct is low-tech.
Federal Laws That Govern Health Insurance Denials and Your Right to Appeal
Before filing a class action, you need to understand the federal framework that governs how insurers must handle claims and denials. Under ERISA, plan administrators must decide claims within 90 days (or 180 days with an extension) and provide written reasons for any denial. Claimants then have 60 days to file an internal appeal, though for urgent care situations, that deadline can be as short as three days. Critically, claimants have the right to review all documents the insurer used in making its denial decision, and the insurer must provide those documents free of charge within 30 days. If your insurer failed to meet any of these requirements, that failure itself can become evidence in a class action. The Affordable Care Act added another layer of protection.
Under the ACA, insurers must respond to appeals within 72 hours for urgent cases, 30 days for non-urgent pre-service decisions, or 60 days for post-service claims. If the internal appeal fails, you have the right to an external review by an independent third party, which must be decided within 45 days for standard reviews or 72 hours for expedited ones. These external reviews are binding on the insurer, and a pattern of losing external reviews can be powerful evidence in a class action that the insurer’s denial practices were systematically flawed. Here is the limitation that catches many people off guard: ERISA often caps your recovery at the value of the denied benefit, plus attorney’s fees. You generally cannot recover punitive damages or emotional distress damages under ERISA, which is why plaintiffs’ attorneys look for ways to frame claims under state law when possible. The Consolidated Appropriations Act of 2021 introduced new fee disclosure requirements that have opened another avenue — plaintiffs’ attorneys are increasingly filing class actions against group health plan fiduciaries for breaching their ERISA duties, arguing that plan sponsors failed to adequately oversee the insurer’s claims practices.
How State Laws Are Strengthening Your Right to Challenge Denials
State legislatures have been aggressively expanding patient protections against improper denials. At least 32 states have enacted or substantially amended health insurance appeal laws since January 2023, creating a patchwork of new rights that vary significantly depending on where you live. This is where your geography can substantially affect the strength of a potential class action claim. New York enacted one of the most aggressive reforms in March 2025, requiring independent clinical specialist review of all medical necessity denials before the denial is even issued — not just on appeal. The law also mandates that insurers disclose when AI was used in a denial decision, which gives plaintiffs valuable information for class action litigation.
Compare that to Massachusetts, where the MHEAR Act, effective January 2025, takes a different approach: it creates a presumption of medical necessity for mental health treatment recommended by a licensed provider, effectively shifting the burden to insurers to prove that treatment is not necessary. California’s SB 1120, the Physicians Make Decisions Act, went into effect in January 2025 and limits the ability of insurers to override physician treatment decisions. The tradeoff with state-law claims is that they only apply to state-regulated plans, not to self-funded employer plans governed by ERISA. If your employer self-funds its health plan (as many large employers do), you are stuck in the ERISA framework regardless of what your state has enacted. However, if you purchased your insurance on the individual market, through a state exchange, or through a fully insured group plan, state-law protections apply and may offer more generous remedies, including the possibility of punitive damages that ERISA does not allow. Lawmakers in more than a dozen states are also considering measures to specifically limit AI use in claims review, which could create new causes of action for class litigation in the near future.
The Denial Rate Crisis and Why 77% of Denials Are Not About Medicine
One of the most damning statistics in health insurance is that 77% of claim denials stem from paperwork or plan design issues, not medical judgment. That means the vast majority of denials are not a doctor disagreeing with your treatment — they are administrative rejections based on coding errors, missing documentation, prior authorization failures, or plan exclusion technicalities. This distinction is crucial for class actions because it undercuts the insurer’s primary defense that denial decisions require individualized medical expertise. The problem is getting worse for providers, which affects patients downstream. In 2025, 41% of healthcare providers report that over 10% of their claims are denied, up from 30% in 2022. When providers face high denial rates, they spend more resources on appeals, pass costs along to patients, or simply stop offering certain services.
Denial rates also vary wildly by geography — by as much as 500% across states. Hawaii and Alaska have the highest rates at 26.9% and 25.5% respectively, while South Dakota sits at just 5.4%. If you are building a class action, these geographic disparities can help define the class and demonstrate that the insurer applied different standards to different populations. A warning for potential class members: high denial rates alone do not prove wrongdoing. Insurers will argue that denials reflect legitimate application of plan terms, not systematic abuse. The strongest class actions pair high denial statistics with specific evidence of flawed processes — an algorithm that was never validated, a policy of denying first and reviewing only on appeal, or internal communications showing that denial targets were set for financial rather than clinical reasons. The nH Predict tool’s 90% error rate on appeal in the UnitedHealth case is exactly the kind of evidence that transforms a statistical argument into a viable lawsuit.
How ERISA Fiduciary Claims Are Opening a New Front Against Insurers
Following the Consolidated Appropriations Act of 2021 and its new fee disclosure requirements, a growing number of class actions are targeting not just insurers but the employer plan fiduciaries who selected and oversaw them. Under ERISA, fiduciaries have a duty to act prudently and in the interest of plan participants. If a plan sponsor hired an insurer or third-party administrator that used defective AI tools or systematically denied valid claims, the fiduciary may be liable for failing to monitor the arrangement.
This matters for policyholders because it opens a second potential defendant — your employer’s benefits committee or plan administrator — and creates use that did not previously exist. For example, if your employer’s plan used UnitedHealth as its administrator and UnitedHealth deployed the nH Predict tool to process your claims, your employer’s plan fiduciary may have had an obligation to investigate whether that tool was producing accurate results. The failure to do so could constitute a separate ERISA violation, giving class action attorneys another path to recovery.
What Comes Next for Health Insurance Denial Class Actions
The next twelve to eighteen months will be pivotal. The Lokken, Cigna, and Humana cases are all moving through discovery, and the evidence that emerges about how AI denial tools actually function will shape litigation strategy for years. If courts continue certifying classes and allowing bad faith claims to proceed, insurers will face enormous financial exposure that could force changes to claims processing practices faster than any regulation could.
On the regulatory front, the wave of state legislation targeting AI in claims decisions is accelerating. As more states require disclosure of AI use in denials and mandate human clinical review, insurers will either need to retool their processes or face a steady stream of new class actions built on statutory violations. The combination of litigation pressure and legislative action is creating more accountability in the denial process than at any point in the last two decades — but policyholders still need to understand their rights and act on them to benefit.
Frequently Asked Questions
Do I need to exhaust my appeals before joining a class action?
In most cases, yes. ERISA generally requires you to complete the plan’s internal appeals process before filing suit. However, courts have recognized exceptions when the appeals process itself is inadequate or when requiring exhaustion would be futile — for example, if the insurer used the same flawed AI tool for appeals that it used for the initial denial.
Can I join a class action if my employer provides my health insurance?
Yes, but your claims will likely be governed by ERISA rather than state law, which limits available remedies. Most of the major AI denial class actions involve employer-sponsored plans and are proceeding under ERISA. You can still participate, but you generally cannot recover punitive damages.
What can I recover in a health insurance denial class action?
Under ERISA, recovery is typically limited to the value of the denied benefits plus attorney’s fees. Under state law (for individually purchased or fully insured plans), you may also be able to recover punitive damages, emotional distress damages, and statutory penalties, depending on your state. The Lokken case against UnitedHealth includes bad faith claims that could expand damages beyond benefit value.
How do I know if my denial was generated by AI?
Several new state laws, including New York’s March 2025 reform, now require insurers to disclose when AI was used in denial decisions. You can also request all documents used in the denial decision — insurers must provide them free within 30 days under ERISA. Look for references to algorithmic tools, predictive models, or automated review systems in the denial documentation.
What is the deadline for filing a health insurance class action?
Statutes of limitations vary. ERISA does not specify a uniform deadline, so courts typically apply the most analogous state statute of limitations, which can range from one to six years. For state-law claims, deadlines depend on the cause of action and jurisdiction. Do not wait — the sooner you consult an attorney, the better your options.
You Might Also Like
- Can You File a Class Action Against a Telehealth Company
- Can You File a Class Action Against a Doctor for Overprescribing
- Can You Join a Class Action Against a Pharmacy for Wrong Medication